Apricot Bio
Apricot BIO provides an image‑based single‑cell profiling platform that measures drug response phenotypes across a panel of cancer therapeutics. The 4i Drug Response Profiling (4iDRP) assay generates deep molecular data within 5–7 days to identify the most effective treatment for each patient. The resulting datasets support biomarker discovery, clinical trial stratification, and drug development applications.
Traction –/10
HQ unknown
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Apricot BIO provides an image‑based single‑cell profiling platform that measures drug response phenotypes across a panel of cancer therapeutics. The 4i Drug Response Profiling (4iDRP) assay generates deep molecular data within 5–7 days to identify the most effective treatment for each patient. The resulting datasets support biomarker discovery, clinical trial stratification, and drug development applications.